相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer
Sudhakar Jinka et al.
BIOMEDICAL MATERIALS (2021)
Self-Assembling Derivative of Hydrocortisone as Glucocorticoid Receptor-Targeted Nanotherapeutics for Synergistic, Combination Therapy against Colorectal Tumor
Kathyayani Sridharan et al.
MOLECULAR PHARMACEUTICS (2021)
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
Theresa E. Hickey et al.
NATURE MEDICINE (2021)
Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer
Shidong Lv et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
Eva Estebanez-Perpina et al.
CANCERS (2021)
The Cardiac Mineralocorticoid Receptor (MR): A Therapeutic Target Against Ventricular Arrhythmias
Michel F. Rossier
FRONTIERS IN ENDOCRINOLOGY (2021)
Estrogen receptor-mediated targeting of the extracellular matrix network in cancer
Zoi Piperigkou et al.
SEMINARS IN CANCER BIOLOGY (2020)
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial
George W. Sledge et al.
JAMA ONCOLOGY (2020)
Combination treatment of bicalutamide and curcumin has a strong therapeutic effect on androgen receptor-positive triple-negative breast cancers
Shengli Dong et al.
ANTI-CANCER DRUGS (2020)
Methoxy-enriched cationic stilbenes as anticancer therapeutics
Md Yousuf et al.
BIOORGANIC CHEMISTRY (2020)
GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models
Shanchun Guo et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
Kaitlyn J. Andreano et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Recent progress in biomedical applications of RGD-based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review
Mohsen Alipour et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2020)
Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope
Sirin Saranyutanon et al.
CANCERS (2020)
Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells
Neeraj Chauhan et al.
ACS OMEGA (2020)
Nandrolone induces a stem cell-like phenotype in human hepatocarcinoma-derived cell line inhibiting mitochondrial respiratory activity
Francesca Agriesti et al.
SCIENTIFIC REPORTS (2020)
A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation
Camille Lafront et al.
SCIENTIFIC REPORTS (2020)
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghba et al.
CELL COMMUNICATION AND SIGNALING (2020)
Magnetic casein-CaFe2O4 nanohybrid carrier conjugated with progesterone for enhanced cytotoxicity of citrus peel derived hesperidin drug towards breast and ovarian cancer
Bindhya K. Purushothaman et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Targeting Krasg12c-mutant cancer with a mutation-specific inhibitor
J. G. Christensen et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Discovery of GNE-149 as a Full Antagonist and Efficient Degrader of Estrogen Receptor alpha for ER plus Breast Cancer
Jun Liang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Combating Glioblastoma by Codelivering the Small-Molecule Inhibitor of STAT3 and STAT3siRNA with α5β1 Integrin Receptor-Selective Liposomes
Venugopal Vangala et al.
MOLECULAR PHARMACEUTICS (2020)
Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy
Zohreh Mohammadi et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia
Vijay Sagar Madamsetty et al.
LEUKEMIA & LYMPHOMA (2020)
Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow
Johanna M. Buschhaus et al.
ONCOGENE (2020)
Down-regulation of ER-α36 mRNA in serum exosomes of the patients with hepatocellular carcinoma
Hui Huang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy
Zehuan Liao et al.
CELLULAR IMMUNOLOGY (2019)
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
Rita S. Mehta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of the in vivo genotoxicity of liposomal formulation for delivering anticancer estrogenic derivative (ESC8) in a mouse model
Ajaz Ahmad et al.
SAUDI PHARMACEUTICAL JOURNAL (2019)
Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling
Chunyan Hu et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
Ghanbar Mahmoodi Chalbatani et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index
Nicole Bechmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
Hong Sheng Cheng et al.
MOLECULAR CANCER (2019)
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis
Wei-Min Chung et al.
CANCERS (2019)
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Jihye Yoo et al.
CANCERS (2019)
Efficient anti-tumor nano-lipoplexes with unsaturated or saturated lipid induce differential genotoxic effects in mice
Hari Krishnareddy Rachamalla et al.
NANOTOXICOLOGY (2019)
Androgen receptor promotes oral squamous cell carcinoma cell migration by increasing EGFR phosphorylation
Xin Liu et al.
ONCOTARGETS AND THERAPY (2019)
The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
David Rodriguez et al.
CANCERS (2019)
iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers
Houdong Zuo
JOURNAL OF ONCOLOGY (2019)
Folic Acid Receptor-Mediated Targeting Enhances the Cytotoxicity, Efficacy, and Selectivity of Withania somnifera Leaf Extract: In vitro and in vivo Evidence
Yue Yu et al.
FRONTIERS IN ONCOLOGY (2019)
Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage
Payel Chatterjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
Stefania Gorini et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer The MANTA Phase 2 Randomized Clinical Trial
Peter Schmid et al.
JAMA ONCOLOGY (2019)
Progesterone Receptor B signaling Reduces Breast Cancer Cell Aggressiveness: Role of Cyclin-D1/Cdk4 Mediating Paxillin Phosphorylation
Francesca Ida Montalto et al.
CANCERS (2019)
Recent advances in nanotheranostics for triple negative breast cancer treatment
Vikram Thakur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Increased glucocorticoid receptor activity and proliferation in metastatic colon cancer
Dan Tian et al.
SCIENTIFIC REPORTS (2019)
Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells
Nian-Kang Sun et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Breast Cancer: Targeting mutant estrogen receptors
Suzanne E. Wardell et al.
ELIFE (2019)
Enhancement of therapeutic effect in breast cancer with a steroid-conjugated ruthenium complex
Gaochao Lv et al.
NEW JOURNAL OF CHEMISTRY (2019)
In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles
Suresh Kumar Gulla et al.
BIOMATERIALS SCIENCE (2019)
Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics
Yuehua Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere-cationic folate nanoconjugate
Chandra Kumar Elechalawar et al.
NANOSCALE ADVANCES (2019)
Shikimoyl-ligand decorated gold nanoparticles for use in ex vivo engineered dendritic cell based DNA vaccination
Rakeshchandra R. Meka et al.
NANOSCALE (2019)
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery
Danielle E. Large et al.
ADVANCED THERAPEUTICS (2019)
Advanced microscopic evaluation of parallel type I and type II cell deaths induced by multi-functionalized gold nanocages in breast cancer
Sreejith Raveendran et al.
NANOSCALE ADVANCES (2019)
Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer
Elisabeth Perez-Ruiz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer
Huan Yang et al.
ACTA BIOMATERIALIA (2018)
Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer
Karen K. L. Chan et al.
CANCER CELL INTERNATIONAL (2018)
An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells
Xueze Zhao et al.
CHEMICAL COMMUNICATIONS (2018)
Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer
Caroline A. Lamb et al.
ENDOCRINE-RELATED CANCER (2018)
Antitumour Activity and Safety of Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Abiraterone Acetate Plus Prednisone for ≥24 weeks in Europe
Johann S. de Bono et al.
EUROPEAN UROLOGY (2018)
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
Emmanuel S. Antonarakis et al.
EUROPEAN UROLOGY (2018)
Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts
Zuzanna Drebert et al.
EXPERIMENTAL CELL RESEARCH (2018)
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer
Tiffany A. Traina et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Oestrogen receptor-mediated liposomal drug delivery for treating melanoma
Anirban Ganguly et al.
JOURNAL OF DRUG TARGETING (2018)
Genome-wide analysis of AR binding and comparison with transcript expression in primary human fetal prostate fibroblasts and cancer associated fibroblasts
Claire Nash et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2-and CXCL8-mediated cancer cell migration
Bianca Cioni et al.
MOLECULAR ONCOLOGY (2018)
Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages
Sofia Raniolo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy
Tengfei Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Systemic Therapy for Colon Cancer
Christina Wu
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system
Kaijian Ling et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy
Najla M. Salkho et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER plus breast cancer
Kanchan Chauhan et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition
Lihua Peng et al.
PLOS ONE (2018)
Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells
Seyung S. Chung et al.
Oncotarget (2018)
Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression
Thea Grindstad et al.
SCIENTIFIC REPORTS (2018)
Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate
Christian Brand et al.
EJNMMI RESEARCH (2018)
Fluorescence imaging of invasive head and neck carcinoma cells with integrin αvβ6-targeting RGD-peptides: an approach to a fluorescence-assisted intraoperative cytological assessment of bony resection margins
M. Nieberler et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2018)
Androgen and Androgen Receptor as Enhancers of M2 Macrophage Polarization in Allergic Lung Inflammation
Mireya Becerra-Diaz et al.
JOURNAL OF IMMUNOLOGY (2018)
Mechanisms for estrogen receptor expression in human cancer
Hui Hua et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways
Gregory S. Y. Ong et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells
Chun-peng Liao et al.
ENDOCRINE-RELATED CANCER (2017)
Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids
Fred Luehder et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles
Elena Montes-Cobos et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment
Meirong Huo et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs
Todd P. Knutson et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Enhanced Spacer Length between Mannose Mimicking Shikimoyl and Quinoyl Headgroups and Hydrophobic Region of Cationic Amphiphile Increases Efficiency of Dendritic Cell Based DNA Vaccination: A Structure-Activity Investigation
Chandrashekhar Voshavar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug
Samaresh Sau et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox-regulated mechanisms
Nina Queisser et al.
MOLECULAR CARCINOGENESIS (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor
Zuzanna Drebert et al.
VASCULAR PHARMACOLOGY (2017)
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
Martina S. J. McDermott et al.
ONCOTARGET (2017)
Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression
Chandra Kumar Elechalawar et al.
BIOMATERIALS SCIENCE (2017)
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Greg H. Tesch et al.
FRONTIERS IN PHARMACOLOGY (2017)
Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells
Chun-Yu Liu et al.
PLOS ONE (2017)
A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
Tobias G. Kapp et al.
SCIENTIFIC REPORTS (2017)
The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature
Zachary Belden et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Effective improvement of the neuroprotective activity after spinal cord injury by synergistic effect of glucocorticoid with biodegradable amphipathic nanomicelles
YueLong Wang et al.
DRUG DELIVERY (2017)
Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
Hugues de The et al.
CANCER CELL (2017)
Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells
Jayant Dewangan et al.
APOPTOSIS (2017)
Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III
Jessica Finlay-Schultz et al.
CANCER RESEARCH (2017)
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide
D. E. Rathkopf et al.
ANNALS OF ONCOLOGY (2017)
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu et al.
CELL (2017)
An Integrin-Targeting RGDK-Tagged Nanocarrier: Anticancer Efficacy of Loaded Curcumin
Krishnendu Das et al.
CHEMMEDCHEM (2017)
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
Susanne Schueler-Toprak et al.
BMC CANCER (2017)
A Review of Fulvestrant in Breast Cancer
Mark R. Nathan et al.
ONCOLOGY AND THERAPY (2017)
Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting
Diego Alberti et al.
CHEMMEDCHEM (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity
Alexios Matikas et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Tumor penetrating peptides for improved drug delivery
Erkki Ruoslahti
ADVANCED DRUG DELIVERY REVIEWS (2017)
Stable Peptides Instead of Stapled Peptides: Highly Potent αvβ6-Selective Integrin Ligands
Oleg V. Maltsev et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
Jack Schalken et al.
BJU INTERNATIONAL (2016)
The influence of subclonal resistance mutations on targeted cancer therapy
Michael W. Schmitt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model
Lingdong Quan et al.
PHARMACEUTICAL RESEARCH (2016)
Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study
Mahesh M. Kumar et al.
TUMOR BIOLOGY (2016)
Current management of newly diagnosed acute promyelocytic leukemia
L. Cicconi et al.
ANNALS OF ONCOLOGY (2016)
17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling
Seulki Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Mineralocorticoid receptor mediated liposomal delivery system for targeted induction of apoptosis in cancer cells
Priyanka Sharma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
Shouhui Yang et al.
CANCER RESEARCH (2016)
AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models
Hazel M. Weir et al.
CANCER RESEARCH (2016)
Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study
Kari B. Wisinski et al.
CLINICAL BREAST CANCER (2016)
Cationic lipid-conjugated hydrocortisone as selective antitumor agent
Bhowmira Rathore et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Laponite as carrier for controlled in vitro delivery of dexamethasone in vitreous humor models
Jose M. Fraile et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort
Matthew R. Smith et al.
EUROPEAN UROLOGY (2016)
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer
Floor J. Backes et al.
GYNECOLOGIC ONCOLOGY (2016)
The Non-Conventional Effects of Glucocorticoids in Cancer
Simra Azher et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes
Dian-Jang Lee et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery
Ying-Zheng Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2016)
What's new in estrogen receptor action in the female reproductive tract
Sylvia C. Hewitt et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model
Noemie Tentillier et al.
JOURNAL OF NEUROSCIENCE (2016)
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Massimo Cristofanilli et al.
LANCET ONCOLOGY (2016)
Estrogen receptor a in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment
Chiuan-Ren Yeh et al.
MOLECULAR CANCER (2016)
Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth
Sugata Barui et al.
MOLECULAR PHARMACEUTICS (2016)
Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-Like Cells and its Pharmacokinetics in an Animal Model
Ajaz Ahmad et al.
MOLECULAR PHARMACEUTICS (2016)
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors
Sujan Kumar Mondal et al.
MOLECULAR PHARMACEUTICS (2016)
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response
Arup Garu et al.
MOLECULAR THERAPY (2016)
Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression
Pritha Agarwalla et al.
NANOMEDICINE (2016)
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D. Campbell et al.
NATURE GENETICS (2016)
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Jonathan M. L. Ostrem et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors
Ellis R. Levin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
Rishabh Kala et al.
PLOS ONE (2016)
Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells
Minqian Shen et al.
PLOS ONE (2016)
New dimension of glucocorticoids in cancer treatment
Kai-Ti Lin et al.
STEROIDS (2016)
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models1
Jose F. Ponte et al.
NEOPLASIA (2016)
N-end rule pathway inhibition assists colon tumor regression via necroptosis
Pritha Agarwalla et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status
Adi Pais et al.
FRONTIERS IN ONCOLOGY (2016)
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
F. Jaisser et al.
PHARMACOLOGICAL REVIEWS (2016)
Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases
Matthias Bartneck et al.
BIOMATERIALS (2015)
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
M. Dietel et al.
CANCER GENE THERAPY (2015)
Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
Raffaele Califano et al.
CANCER TREATMENT REVIEWS (2015)
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24
Jair Bar et al.
CLINICAL LUNG CANCER (2015)
Synthesis of amphiphilic resveratrol lipoconjugates and evaluation of their anticancer activity towards neuroblastoma SH-SY5Y cell line
Rosa Chillemi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma
Huizhen Nie et al.
HEPATOLOGY (2015)
Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients
Rodrigo Dienstmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts
Andiliy Lai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts
Zuzanna Drebert et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Future options for ALK-positive non-small cell lung cancer
Daniela Iacono et al.
LUNG CANCER (2015)
Lipid Nanocarriers of a Lipid-Conjugated Estrogenic Derivative Inhibit Tumor Growth and Enhance Cisplatin Activity against Triple-Negative Breast Cancer: Pharmacokinetic and Efficacy Evaluation
Terrick Andey et al.
MOLECULAR PHARMACEUTICS (2015)
Targeting FR-expressing cells in ovarian cancer with Fab-functionalized nanoparticles: a full study to provide the proof of principle from in vitro to in vivo
Alessandra Quarta et al.
NANOSCALE (2015)
In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel
Poonam Saraf et al.
PHARMACEUTICAL RESEARCH (2015)
Progesterone Receptor Expression During Prostate Cancer Progression Suggests a Role of This Receptor in Stromal Cell Differentiation
Yue Yu et al.
PROSTATE (2015)
Targeting the glucocorticoid receptor in breast and prostate cancers
Jacob Kach et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome
Damien A. Leach et al.
ONCOTARGET (2015)
Identification of estrogen-responsive genes based on the DNA binding properties of estrogen receptors using high-throughput sequencing technology
Kazuhiro Ikeda et al.
ACTA PHARMACOLOGICA SINICA (2015)
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial
D. Klingbiel et al.
ANNALS OF ONCOLOGY (2015)
Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer
Yunfei Wen et al.
CLINICAL CANCER RESEARCH (2015)
A brief history of cancer: Age-old milestones underlying our current knowledge database
Guy B. Faguet
INTERNATIONAL JOURNAL OF CANCER (2015)
Quantitative Nuclear Proteomics Identifies that miR-137-mediated EZH2 Reduction Regulates Resveratrol-induced Apoptosis of Neuroblastoma Cells
Xiaoqing Ren et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
The oncogenic role of androgen receptors in promoting the growth of oral squamous cell carcinoma cells
T-F Wu et al.
ORAL DISEASES (2015)
Activation of KRAS promotes the mesenchymal features of basal-type breast cancer
Rae-Kwon Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Inhibitory Effect of Genistein on PLC/PRF5 Hepatocellular Carcinoma Cell Line
Mehdi Nikbakht Dastjerdi et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2015)
Nanomedicines for Inflammatory Arthritis: Head-to-Head Comparison of Glucocorticoid-Containing Polymers, Micelles, and Liposomes
Lingdong Quan et al.
ACS NANO (2014)
Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy
Jitender Madan et al.
ANTI-CANCER DRUGS (2014)
Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature
Sugata Barui et al.
BIOMATERIALS (2014)
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
John C. Castle et al.
BMC GENOMICS (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Bis-arylidene Oxindoles as Anti-Breast-Cancer Agents Acting via the Estrogen Receptor
Abhishek Pal et al.
CHEMMEDCHEM (2014)
Toremifene for Breast Cancer: A Review of 20 Years of Data
Charles L. Vogel et al.
CLINICAL BREAST CANCER (2014)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis
A. S. Vanniasinghe et al.
CLINICAL IMMUNOLOGY (2014)
Evidence of androgen action in endometrial and ovarian cancers
Douglas A. Gibson et al.
ENDOCRINE-RELATED CANCER (2014)
Development of new estradiol-cationic lipid hybrids: Ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity
Godeshala Sudhakar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Cationic lipid-conjugated dexamethasone as a selective antitumor agent
Samaresh Sau et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Targeting the androgen receptor in prostate cancer
Zoran Culig
EXPERT OPINION ON PHARMACOTHERAPY (2014)
CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
Stacey Shiovitz et al.
GASTROENTEROLOGY (2014)
Evidence for aldosterone-dependent growth of renal cell carcinoma
Sharon King et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2014)
Macromolecular prodrug of dexamethasone prevents particle-induced peri-implant osteolysis with reduced systemic side effects
Ke Ren et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Inhibiting tumor growth by targeting liposomally encapsulated CDC20siRNA to tumor vasculature: Therapeutic RNA interference
Poulami Majumder et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis
De-Hyung Lee et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Inhibition of hepatocellular carcinoma by fulvestrant involves the estrogen receptor α and Wnt pathways in vitro and in patients
Cong-Jun Wang et al.
MOLECULAR MEDICINE REPORTS (2014)
Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation
Dai-Ying Zhou et al.
MOLECULAR MEDICINE REPORTS (2014)
Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle
Samaresh Sau et al.
NANOSCALE (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Prostate Stromal Cells Express the Progesterone Receptor to Control Cancer Cell Mobility
Yue Yu et al.
PLOS ONE (2014)
Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells
Margherita Piccolella et al.
PHARMACOLOGICAL RESEARCH (2014)
Tracking progesterone receptor-mediated actions in breast cancer
Todd P. Knutson et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Approach for targeting Ras with small molecules that activate SOS-mediated nucleotide exchange
Michael C. Burns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
Bo Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann et al.
BREAST CANCER RESEARCH (2014)
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines
Pietro Rizza et al.
BREAST CANCER RESEARCH (2014)
Dendritic cell immunotherapy: clinical outcomes
Vasso Apostolopoulos et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)
The Multifaceted Mineralocorticoid Receptor
Elise Gomez-Sanchez et al.
COMPREHENSIVE PHYSIOLOGY (2014)
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R. Cochrane et al.
BREAST CANCER RESEARCH (2014)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Molecular Profiling in Non-Small Cell Lung Cancer
Kirtee Raparia et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect
Subrata Kumar Pore et al.
BIOMATERIALS (2013)
The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor
Goutam Mondal et al.
BIOMATERIALS (2013)
Epidermal growth factor receptor targeting in cancer: A review of trends and strategies
Chetan Yewale et al.
BIOMATERIALS (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides
Alessandro Pileri et al.
IMMUNOTHERAPY (2013)
Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature
Goutam Mondal et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
Martin Widschwendter et al.
LANCET ONCOLOGY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Strategies for optimizing the response of cancer and normal tissues to radiation
Everett J. Moding et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion
Shengqiang Yu et al.
MEDICAL ONCOLOGY (2013)
Update on Raloxifene: Mechanism of Action, Clinical Efficacy, Adverse Effects, and Contraindications
Salvatore Gizzo et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2013)
Progesterone inhibits the migration and invasion of A549 lung cancer cells through membrane progesterone receptor α-mediated mechanisms
Mingxuan Xie et al.
ONCOLOGY REPORTS (2013)
The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer
Laura Tiberio et al.
PLOS ONE (2013)
Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells
Jin Xie et al.
ONCOLOGY LETTERS (2013)
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Nora Graf et al.
ACS NANO (2012)
Antiandrogen Gold Nanoparticles Dual-Target and Overcome Treatment Resistance in Hormone-Insensitive Prostate Cancer Cells
Erik C. Dreaden et al.
BIOCONJUGATE CHEMISTRY (2012)
A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups
Ramishetti Srinivas et al.
BIOMATERIALS (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-α in human proximal tubular cells
Kento Kitada et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo
Fiona Simpkins et al.
CLINICAL CANCER RESEARCH (2012)
Antiprogestins in breast cancer treatment: are we ready?
Claudia Lanari et al.
ENDOCRINE-RELATED CANCER (2012)
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
Ahmed Elattar et al.
GYNECOLOGIC ONCOLOGY (2012)
Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo
Justin B. Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma
Dong Ta Zhong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
The tumor microenvironment at a glance
Frances R. Balkwill et al.
JOURNAL OF CELL SCIENCE (2012)
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
Pieter J. Gaillard et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines
Rina Ulmansky et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Mechanisms of ligand specificity of the mineralocorticoid receptor
Peter J. Fuller et al.
JOURNAL OF ENDOCRINOLOGY (2012)
EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model
Manish Tandon et al.
JOURNAL OF GENE MEDICINE (2012)
Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats
Ivo A. C. W. Tiebosch et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells
Nicole L. Moore et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Estrogen-Anchored pH-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer Therapy
Shivani R. Paliwal et al.
MOLECULAR PHARMACEUTICS (2012)
Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice
Jun Yang et al.
NANOMEDICINE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms
Ming-Xiang Ye et al.
PHYTOMEDICINE (2012)
A Novel Classification of Lung Cancer into Molecular Subtypes
Lisandra West et al.
PLOS ONE (2012)
Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
Carine Bossard et al.
PLOS ONE (2012)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Glucocorticoid receptor signaling and prostate cancer
E. Kassi et al.
CANCER LETTERS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Aldosterone/Mineralocorticoid Receptor Stimulation Induces Cellular Senescence in the Kidney
Yu-Yan Fan et al.
ENDOCRINOLOGY (2011)
Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis
W. Hofkens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis
Wouter Hofkens et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Liposomal Encapsulation of Glucocorticoids Alters Their Mode of Action in the Treatment of Experimental Autoimmune Encephalomyelitis
Nils Schweingruber et al.
JOURNAL OF IMMUNOLOGY (2011)
Structure-Activity Study To Develop Cationic Lipid-Conjugated Haloperidol Derivatives as a New Class of Anticancer Therapeutics
Krishnendu Pal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Lipid-Modified Estrogen Derivative that Treats Breast Cancer Independent of Estrogen Receptor Expression through Simultaneous Induction of Autophagy and Apoptosis
Sutapa Sinha et al.
MOLECULAR CANCER RESEARCH (2011)
17β-Estradiol-Linked Nitro-L-arginine as Simultaneous Inducer of Apoptosis in Melanoma and Tumor-Angiogenic Vascular Endothelial Cells
Sayantani Roy et al.
MOLECULAR PHARMACEUTICS (2011)
The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor α and Cyclin D1
Joan S. Lewis-Wambi et al.
MOLECULAR PHARMACOLOGY (2011)
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
Gooitzen M. van Dam et al.
NATURE MEDICINE (2011)
αv Integrins in Angiogenesis and Cancer
Sara M. Weis et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Progesterone receptor action: defining a role in breast cancer
Andrea R. Daniel et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
The use of RGDGWK-lipopeptide to selectively deliver genes to mouse tumor vasculature and its complexation with p53 to inhibit tumor growth
Sanjoy Samanta et al.
BIOMATERIALS (2010)
Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?
Tito Fojo et al.
CLINICAL CANCER RESEARCH (2010)
A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy
S. R. Paliwal et al.
CURRENT CANCER DRUG TARGETS (2010)
Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh
Joel W. Neal et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2010)
Cationic Amphiphile with Shikimic Acid Headgroup Shows More Systemic Promise Than Its Mannosyl Analogue as DNA Vaccine Carrier in Dendritic Cell Based Genetic Immunization
Ramishetti Srinivas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Nuclear hormone receptors in diabetic nephropathy
Xiaoxin X. Wang et al.
NATURE REVIEWS NEPHROLOGY (2010)
Curcumin interrupts the interaction between the androgen receptor and Wnt/β-catenin signaling pathway in LNCaP prostate cancer cells
H. Y. Choi et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy
Ling-dong Quan et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer
Frederic Buxant et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2010)
Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis
U. Rauchhaus et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
G. L. Semenza
CURRENT PHARMACEUTICAL DESIGN (2009)
Targeted delivery of an anti-cancer agent via steroid coupled liposomes
Pramod K. Mishra et al.
DRUG DELIVERY (2009)
Reovirus-based therapy for cancer
Kevin Kelly et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
MicroRNA-18a Prevents Estrogen Receptor-α Expression, Promoting Proliferation of Hepatocellular Carcinoma Cells
Wan-Hsin Liu et al.
GASTROENTEROLOGY (2009)
The mineralocorticoid receptor and its coregulators
Jun Yang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)
Purification and characterization of recombinant human mineralocorticoid receptor
Colin D. Clyne et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
J. Rainer et al.
LEUKEMIA (2009)
Selective Cancer Targeting via Aberrant Behavior of Cancer Cell-associated Glucocorticoid Receptor
Amarnath Mukherjee et al.
MOLECULAR THERAPY (2009)
Well-Done Meat Intake, Heterocyclic Amine Exposure, and Cancer Risk
Wei Zheng et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms
Evgeny Yakirevich et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy
Bruce D. Keith
BMC CANCER (2008)
Analysis of overall survival in patients with nonmetastatic castration-resistant prostate cancer treated with vaccine, nilutamide, and combination therapy
Ravi A. Madan et al.
CLINICAL CANCER RESEARCH (2008)
Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination:: Long-term protective effects and enhanced efficacy of methylprednisolone formulations
Ralf A. Linker et al.
EXPERIMENTAL NEUROLOGY (2008)
Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma
Cheng-Lung Ma et al.
GASTROENTEROLOGY (2008)
Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion
Yirong Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice
Manuela Banciu et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Lipopeptide with a RGDK Tetrapeptide Sequence Can Selectively Target Genes to Proangiogenic α5β1 Integrin Receptor and Mouse Tumor Vasculature
Dipankar Pramanik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors
Emily J. Faivre et al.
MOLECULAR ENDOCRINOLOGY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Estrogen receptor subtypes in ovarian cancer - A clinical correlation
Karen K. L. Chan et al.
OBSTETRICS AND GYNECOLOGY (2008)
Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells
Xiao-Bing Xiong et al.
PHARMACEUTICAL RESEARCH (2008)
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
Preetha Anand et al.
PHARMACEUTICAL RESEARCH (2008)
Glucocorticoid receptor physiology
Marjet D. Heitzer et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2007)
Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
Alicia A. Goyeneche et al.
CLINICAL CANCER RESEARCH (2007)
Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity
Celine Frochot et al.
BIOORGANIC CHEMISTRY (2007)
Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity
Malathy P. V. Shekhar et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Targeting TRAIL agonistic receptors for cancer therapy
Carmelo Carlo-Stella et al.
CLINICAL CANCER RESEARCH (2007)
Role of the progesterone receptor for paclitaxel resistance in primary breast cancer
M. Schmidt et al.
BRITISH JOURNAL OF CANCER (2007)
Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide
Murielle Mimeault et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems
Jack-Michel Renoir et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Corticosteroid-induced chemotherapy resistance in urological cancers
C Zhang et al.
CANCER BIOLOGY & THERAPY (2006)
Estrogen receptors as therapeutic targets in breast cancer
Eric A. Ariazi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy
E Munzone et al.
BREAST CANCER RESEARCH (2006)
Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
G Arpino et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Haloperidol-associated stealth liposomes - A potent carrier for delivering genes to human breast cancer cells
A Mukherjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production
TM Wintermantel et al.
MOLECULAR ENDOCRINOLOGY (2005)
Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells
JCL Leo et al.
ENDOCRINOLOGY (2004)
Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling
J Murtagh et al.
JOURNAL OF CELL BIOLOGY (2004)
Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance
S Schmidt et al.
CELL DEATH AND DIFFERENTIATION (2004)
Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells
R Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
G Russell-Jones et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Evaluation of an estrogen receptor-β agonist in animal models of human disease
HA Harris et al.
ENDOCRINOLOGY (2003)
Changing paradigms in dermatology: Nuclear hormone receptors
L Winterfield et al.
CLINICS IN DERMATOLOGY (2003)
In vitro and in vivo biologic evaluation of long-circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668
T Ameller et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
B Mulac-Jericevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis
J Schmidt et al.
BRAIN (2003)
A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells
Y Lee et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Efficacy of liposomal budesonide in experimental asthma
KS Konduri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Progesterone receptor transcription and non-transcription signaling mechanisms
SA Leonhardt et al.
STEROIDS (2003)
Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process
S Verrier et al.
BIOMATERIALS (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines
H Nakagawa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Complete androgen blockade for prostate cancer: What went wrong?
M Laufer et al.
JOURNAL OF UROLOGY (2000)
分享论文
